Abstract: . . .  G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommenda- tions of the Second Joint Task Force of European and other Societies on coronary pre- vention. Atherosclerosis 1998;140:199270. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med 1997;157:24132446. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO, 1999. Clinical practice: Consensus statement for the prevention of vascular disease Reprinted from: Australian Family Physician Vol. 33, No. 4, April 2004 239 Correspondence Email: eleanor.clune@heartfoundation. com.au AFP  . . .
. . .  significant independent pre- dictor of progression of renal failure, of vascular disease and of cardiovascular and all cause mortality. Certain antihypertensives, in particular ACE inhibitors and angiotensin 2 receptor antagonists, are antiproteinuric, and their protective effect against progression of renal failure is proportional to the degree of proteinuria and to the degree of its reduction with therapy. Aspirin The value of aspirin therapy in patients with known vascular disease is well established. Its role in primary prevention requires individual assessment of both the risks and benefits. It is often recommended in people with diabetes and in those at high absolute risk of coronary heart disease where no absolute contraindica- tions exist. Resources For more detailed information and support, refer to the following: Diabetes Australia: www.diabetesaustralia. . . .
. . .  European and other Societies on coronary pre- vention. Atherosclerosis 1998;140:199270. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med 1997;157:24132446. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO, 1999. Clinical practice: Consensus statement for the prevention of vascular disease Reprinted from: Australian Family Physician Vol. 33, No. 4, April 2004 239 Correspondence Email: eleanor.clune@heartfoundation. com.au AFP  . . .
--3000,3,500,2843,23892